Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Calcitonin Gene-related Peptide Receptor”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Early research (Phase 1)Study completedNCT01294709
What this trial is testing

Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)

Who this might be right for
Angina PectorisCoronary Heart DiseaseCalcitonin Gene-related Peptide Receptor
Merck Sharp & Dohme LLC 64
Early research (Phase 1)Study completedNCT02542605
What this trial is testing

To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients

Who this might be right for
Migraine
Amgen 35
Post-approval studies (Phase 4)Study completedNCT03828539
What this trial is testing

Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine

Who this might be right for
Migraine
Novartis Pharmaceuticals 777
Testing effectiveness (Phase 2)Looking for participantsNCT05049057
What this trial is testing

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Who this might be right for
Posttraumatic HeadacheMild Traumatic Brain Injury
Henry M. Jackson Foundation for the Advancement of Military Medicine 404
Not applicableStudy completedNCT02273128
What this trial is testing

Assess the Disturbances in Calcitonin Gene in Patients With Gum Disease and Osteoporosis

Who this might be right for
Generalized Chronic PeriodontitisOsteoporosis
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre 50
Testing effectiveness (Phase 2)Ended earlyNCT05142228
What this trial is testing

Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.

Who this might be right for
Trigeminal Neuropathy
University of Maryland, Baltimore 5
Very early researchStudy completedNCT03647657
What this trial is testing

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer, Medullary
University Hospital, Basel, Switzerland 8
Post-approval studies (Phase 4)Study completedNCT04084314
What this trial is testing

Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

Who this might be right for
MigraineMigraine DisordersMigraine Headache
Novartis Pharmaceuticals 701
Early research (Phase 1)Active Not RecruitingNCT02088645
What this trial is testing

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Who this might be right for
Thyroid Cancer, MedullaryNeuroendocrine Tumor of the Lung Grade 1 and 2Neuroendocrine Tumor of the Thymus Grade 1 and 2+1 more
University Hospital, Basel, Switzerland 24
Not applicableUnknownNCT04452929
What this trial is testing

The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

Who this might be right for
MigraineMigraine Without AuraMigraine With Aura
Danish Headache Center 72
Early research (Phase 1)Study completedNCT01315847
What this trial is testing

Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067)

Who this might be right for
Migraine
Merck Sharp & Dohme LLC 10
Testing effectiveness (Phase 2)Ended earlyNCT05162027
What this trial is testing

Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE)

Who this might be right for
Temporomandibular Disorders
University of Maryland, Baltimore 5
Early research (Phase 1)Looking for participantsNCT07261371
What this trial is testing

Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults

Who this might be right for
Healthy Volunteer
Pfizer 64
Large-scale testing (Phase 3)Study completedNCT03096834
What this trial is testing

A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies

Who this might be right for
Episodic Migraine
Novartis Pharmaceuticals 246